Palantir Proves Solutions Are Resonating, Growth Ahead
We are raising our fair value estimate for the narrow-moat company.
We are raising our fair value estimate for narrow-moat Palantir Technologies (PLTR) to $25 from $24 after its first-quarter results left us more bullish about its long-term prospects. While we do not expect GAAP profitability for years, we believe Palantir is prudently investing in ramping up its business to land a wider breadth of organizations from various industries, sizes, and geographic locations. Palantir constitutes a minuscule amount of overall U.S. defense spending and has an embryonic commercial customer base; however, once Palantir’s solutions are installed, we believe organizations can become reliant on its products. With shares trading around $19 in intraday trading, we believe investors have upside to capture in this disruptor.
Palantir’s revenue growth of 49% year over year topped our already aggressive expectations, thanks to resounding results in the government vertical and strong broad-based expansion within the U.S. Government revenue was the bright spot, growing 76% year over year. U.S. government business grew by 83%, led by defense and pandemic-related use cases. We do not believe Palantir’s non-defense government segment will fizzle out after businesses reopen, as we think the company is proving its software capabilities during a time of crisis, which can open the door and lead to proliferation across other government entities working to harness their data.
Commercial sales rose 19% and were impacted by certain geography lockdowns, although U.S.-based commercial growth increased 72% year over year. With Palantir’s push to modularize its offerings and expand its sales reach, commercial opportunities within the U.S. and U.K. increased by 2.5 times and commercial pilots more than doubled since February. Alongside the strong top-line results and expectations of continued strength ahead, Palantir also posted 34% adjusted operating margin (up 200 basis points sequentially) and 44% adjusted free cash flow margin.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Mark Cash does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.